Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women
Clinical trial NCT00481169 · COMPLETED
Trial details
- NCT number
- NCT00481169
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-07-01
- Primary completion
- 2004-07-01
- Enrollment
- 1742
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.